Benazepril Hydrochloride Tablet, Coated
NDC Package 51655-066-52

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Benazepril Hydrochloride tablets is uSP are indicated for the treatment of hypertension. This formulation utilizes a tablet, coated delivery system. Marketed by Northwind Health Company, Llc, this product is identified by NDC 51655-066 and is authorized under FDA application ANDA076118.

Identification & Billing

NDC Package Code
51655-066-52
Package Description
30 TABLET, COATED in 1 BOTTLE, DISPENSING
Product Code
51655-066
11-Digit Billing Format
51655006652
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Benazepril Hydrochloride
Non-Proprietary Name
Benazepril Hydrochloride
Substance Name
Benazepril Hydrochloride
Dosage Form
Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
BENAZEPRIL HYDROCHLORIDE 20 mg/1
Pharmacologic Class
Usage Information
Benazepril hydrochloride tablets, USP are indicated for the treatment of hypertension. It may be used alone or in combination with thiazide diuretics.

Regulatory & Marketing

Labeler Name
Northwind Health Company, Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA076118
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-04-2016
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (51655-066). Click a package code to view its specific billing and regulatory data.

51655-066-26
90 TABLET, COATED in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51655-066-52 identifies a specific commercial package of 30 tablet, coated in 1 bottle, dispensing of Benazepril Hydrochloride, a human prescription drug labeled by Northwind Health Company, Llc. This tablet, coated is formulated for oral use and contains benazepril hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Northwind Health Company, Llc on March 04, 2016. The current certification is valid through December 31, 2027.

How is this Northwind Health Company, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51655006652. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
51655-066-52
11-Digit CMS (5-4-2)
51655-0066-52

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.